Roivant Sciences Ltd (ROIV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,408,231 | 1,434,093 | 1,676,813 | 1,527,437 | 1,603,014 |
| Other current assets | 143,396 | 127,065 | 121,774 | 118,795 | 111,847 |
| TOTAL | $1,551,627 | $1,561,158 | $1,798,587 | $1,646,232 | $1,714,861 |
| Non-Current Assets | |||||
| PPE Net | 24,477 | 36,270 | 39,086 | 37,295 | 39,171 |
| Investments And Advances | 250,393 | 296,243 | 304,317 | 272,469 | 246,609 |
| Intangibles | 140,621 | 145,037 | 144,881 | 146,105 | 140,298 |
| Other Non-Current Assets | 98,425 | 97,938 | 102,733 | 100,859 | 74,595 |
| TOTAL | $513,916 | $575,488 | $591,017 | $556,728 | $500,673 |
| Total Assets | $2,065,543 | $2,136,646 | $2,389,604 | $2,202,960 | $2,215,534 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 48,998 | 44,406 | 40,720 | 37,724 | 35,754 |
| Accounts payable and accrued liabilities | 44,123 | 50,035 | 37,830 | 47,999 | 41,358 |
| Accrued Expenses | 152,923 | 119,329 | 167,129 | 132,359 | 128,815 |
| Other current liabilities | 8,599 | 19,886 | 15,076 | 14,310 | 5,049 |
| TOTAL | $265,546 | $245,004 | $272,448 | $244,255 | $230,744 |
| Non-Current Liabilities | |||||
| Long Term Debt | 389,445 | 385,069 | 375,515 | 375,124 | 376,058 |
| Deferred Revenues | N/A | N/A | N/A | N/A | 8,373 |
| Other Non-Current Liabilities | 111,710 | 208,463 | 161,299 | 189,325 | 107,013 |
| TOTAL | $474,364 | $557,503 | $509,569 | $531,567 | $470,641 |
| Total Liabilities | $739,910 | $802,507 | $782,017 | $775,822 | $701,385 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 803,921 | 771,742 | 766,812 | 758,427 | 725,419 |
| Retained earnings | -4,368,897 | -4,064,570 | -3,772,754 | -3,739,137 | -3,387,123 |
| Other shareholders' equity | 374,027 | 416,799 | 447,204 | 470,889 | 362,637 |
| TOTAL | $1,325,633 | $1,334,139 | $1,607,587 | $1,427,138 | $1,514,149 |
| Total Liabilities And Equity | $2,065,543 | $2,136,646 | $2,389,604 | $2,202,960 | $2,215,534 |